7 results
8-K
EX-99.1
UBX
Unity Biotechnology Inc
13 Nov 23
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results
4:05pm
time sustainable improvement in visual acuity, and UBX1325 could potentially be that option.”
The Phase 2b ASPIRE study in DME is a multi-center
10-K
qmdskmju82bt0 9e1
6 Mar 19
Annual report
8:06am
424B4
zvgr5guff55g 4p9
4 May 18
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next